Jump to content
Wikipedia The Free Encyclopedia

Tropicamide/phenylephrine

From Wikipedia, the free encyclopedia
Medication
Pharmaceutical compound
Tropicamide/phenylephrine
Combination of
Tropicamide Anticholinergic
Phenylephrine Alpha-1 adrenergic receptor agonist
Clinical data
Trade names Mydcombi
Routes of
administration
Topical, ophthalmic
ATC code
Legal status
Legal status

Tropicamide/phenylephrine, sold under the brand name Mydcombi is a fixed dose combination of tropicamide and phenylephrine used to dilate the eyes (mydriasis).[1] It contains, tropicamide, an anticholinergic, and phenylephrine, as the hydrochloride, an alpha-1 adrenergic receptor agonist.[1] It is sprayed into the eyes.[1]

It was approved for medical use in the United States in May 2023.[2] [3]

Medical uses

[edit ]

Tropicamide/phenylephrine is used for the short-term dilation of the pupils.[1]

References

[edit ]
[edit ]
  • Clinical trial number NCT03751631 for "Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation (MIST-1)" at ClinicalTrials.gov
  • Clinical trial number NCT03751098 for "Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation (MIST-2)" at ClinicalTrials.gov
mAChRs Tooltip Muscarinic acetylcholine receptors
Agonists
Antagonists
Precursors
(and prodrugs)
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds


Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

AltStyle によって変換されたページ (->オリジナル) /